BUSINESS UPDTE –Q3 22 © 22 Palanr Technologies Inc. November 22 -- 1 of 40 -- Safe Harbor This presentaon and the accompanying oral commentary contain “forward-looking” statements within the meaning of the federal securies laws, and these statements involve substanal risks and uncertaines. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, expectaons of future operang results or financial performance, market size and growth opportunies, the calculaon of certain of our key financial and operang metrics, plans for future operaons, compeve posion, technological capabilies, and strategic relaonships, as well as assumpons relang to the foregoing. Forward-looking statements are inherently subject to risks and uncertaines, some of which cannot be predicted or quanfied. In some cases, you can idenfy forward-looking statements by terminology such as “guidance,” “expect,” “ancipate,” “should,” “believe,” “hope,” “target,” “project,” “plan,” “goals,” “esmate,” “potenal,” “predict,” “may,” “will,” “might,” “could,” “intend,” “shall,” and variaons of these terms or the negave of these terms and similar expressions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indicaons of the mes at, or by, which such performance or results will be achieved, if at all. Forward-looking statements are subject to a number of risks and uncertaines, many of which involve factors or circumstances that are beyond our control. Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to risks detailed in our filings with the Securies and Exchange Commission (the “SEC”), including in our prospectus filed with the SEC pursuant to Rule 424(b), dated September 22, 2020, our quarterly report on Form 10-Q for the quarter ended September 30, 2020, and other filings and reports that we may file from me to me with the SEC. You can locate these reports on our investor relaons website (hps://investors.palanr.com/financials/sec-filings/) or on the SEC website (www.sec.gov). If the risks or uncertaines ever materialize or the assumpons prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. Except as required by law, we assume no obligaon and do not intend to update these forward-looking statements or to conform these statements to actual results or to changes in our expectaons. We use the non-GAAP financial measures contribuon margin; gross profit and gross margin, excluding stock-based compensaon; and adjusted operang income (loss) and adjusted operang margin to help us evaluate our business, idenfy trends affecng our business, formulate business plans and financial projecons, and make strategic decisions. Our definions may differ from the definions used by other companies and therefore comparability may be limited. In addion, other companies may not publish these or similar metrics. Further, these metrics have certain limitaons in that they do not include the impact of certain expenses that are reflected in our consolidated statement of operaons. Thus, these non-GAAP financial measures should be considered in addion to, not as a substute for, or in isolaon from, measures prepared in accordance with GAAP. We compensate for these limitaons by providing reconciliaons of these non-GAAP financial measures to the most comparable GAAP measures. We encourage investors and others to review our business, results of operaons and financial informaon in its enrety, not to rely on any single financial measure, and to view these non-GAAP financial measures in conjuncon with the most directly comparable GAAP financial measures. This presentaon contains stascal data, esmates and forecasts that are based on independent industry publicaons or other publicly available informaon, as well as other informaon based on our internal sources. This informaon involves many assumpons and limitaons, and you are cauoned not to give undue weight to these esmates. We have not independently verified the accuracy or completeness of the data contained in these industry publicaons and other publicly available informaon. Accordingly, we make no representaons as to the accuracy or completeness of that data nor do we undertake to update such data after the date of this presentaon. This presentaon also contains links to publicly-available websites, data, or other informaon. We have not independently verified the accuracy or completeness of such websites, data, or informaon and accordingly we make no representaons as to their accuracy or completeness nor do we undertake to update such data or informaon after the date of this presentaon. The inclusion of external links does not constute endorsement by Palanr of the linked websites or the data or informaon contained therein. By aending or receiving this presentaon you acknowledge that you will be solely responsible for your own assessment of the market and our market posion and that you will conduct your own analysis and be solely responsible for forming your own view of the potenal future performance of our business. Any non-Palanr logos or trademarks included herein are the property of the owners thereof and are used for reference purposes only. Such use should not be construed as an endorsement of the platform and products of Palanr. -- 2 of 40 -- Congratulaons to the U.S. Jusce Department on its selement with Purdue Pharma and fight against the Opioid epidemic in America. Supporng the Department of Jusce with Palanr Gotham Jusce Department Announces Global Resoluon of Criminal and Civil Invesgaons with Opioid Manufacturer Purdue Pharma and Civil Selement with Members of the Sackler Family OCT 21, 22 DEPRTMENT OF JUSTCE–OFFCE OF PUBLC FFRS Yuri Gripas/AFP via Gey Images RED MORE ↗ -- 3 of 40 -- Congratulaons to the World Food Programme on its Nobel Peace Prize. Supporng WFP with Palanr Foundry World Food Programme UN World Food Programme wins 2020 Nobel Peace Prize, as hunger mounts OCT 9, 22 UN NES–PECE ND SECURT RED MORE ↗ -- 4 of 40 -- U.S. Army photo by Staff Sgt. Marcus Fichtl In awe of and grateful for the service of our Special Operators. October's rescue is yet another amazing accomplishment - one that often goes unrecognized. Supporng Special Operators U.S. Special Operaons Forces Rescue American Hostage In Nigeria OCT 31, 22 NPR–ORLD RED MORE ↗ -- 5 of 40 -- Adjusted operang income (loss) and adjusted operang margin exclude stock-based compensaon, employer taxes related to stock-based compensaon, and expenses primarily related to the direct lisng. Refer to the Appendix for reconciliaons of these non-GAAP financial measures to the most directly comparable GAAP financial measures. Q3 2020 Financial Highlights Revenue FG 1 REENUE Q3 219 Q3 22 $191M $289M +52% Adjusted Operang Income (Loss) FG 2 DJUSTED OPERTNG NCOME (LOSS) Q3 219 Q3 22 ($92M) $73M 25% (48%) DJUSTED OPERTNG MRGN -- 6 of 40 -- COVID-19 forced instuons to transform quickly in order to survive. We are helping those customers do more with less. RED MORE ↗ RED MORE ↗ -- 7 of 40 -- An energy supermajor deployed our ERP suite in hours. Within two weeks, they generated $57 million of cash savings and expect to generate $1 billion on an annualized basis. All data is noonal. RED MORE ↗ TCH DEO ↗ -- 8 of 40 -- All data is noonal. $3 million FE-ER RENEL An aerospace customer signed the largest commercial deal we’ve ever done in the midst of a pandemic that shook their enre industry. TCH DEO ↗ -- 9 of 40 -- All data is noonal. A Fortune 100 consumer goods company deployed ERP Suite to quickly respond to COVID-related disruptions. Now, our platforms are connecting the entire value chain – from procurement to distribution. -- 10 of 40 -- All data is noonal. A top 5 pharmaceucal company is linking data from more than 2,000 clinical trials in Foundry to uncover trends across trials and securely analyze outcomes at a populaon level. -- 11 of 40 -- Our software is becoming the de facto operang system of US and Allied Defense. RED MORE ↗ -- 12 of 40 -- Signed a two-year, $91 million contract with the U.S. Army Research Laboratory. All data is noonal. U.S. Army Research Lab Selects Palanr Technologies Inc. for $91M Arficial Intelligence and Machine Learning Development OCT 1, 22 BUSNESS RE RED MORE ↗ RED MORE ↗ -- 13 of 40 -- All data is noonal. Scaled from an all-domain Common Operang Picture (COP) at the onset of COVID-19 to the JADC2 doctrinal paradigm across all mission areas Inform accurate Course of Acon (COA) development with integrated operaonal readiness data Use AI to evaluate COAs and answer complex paern-of-life quesons in seconds, not hours Enabling Mission Command for NORAD & USNORTHCOM (N / NC) Joint All-Domain Command & Control (JADC2) -- 14 of 40 -- Our software is becoming the infrastructure for the U.S. healthcare system – from R&D to distribuon, from public to private. -- 15 of 40 -- Signed a $36 million contract to support NCATS efforts, including cancer research, COVID-19 research, and PEPFAR. All data is publicly available at hps://covid.cd2h.org/enclave_projects NIH expanding enclave for COVID-19 data with $36M Palanr contract SEP 29, 22 FEDSCOOP–CQUSTON RED MORE ↗ RED MORE ↗ -- 16 of 40 -- All data is publicly available at hps://covid.cd2h.org/enclave_projects The ambious effort to piece together America’s fragmented health data OCT 19, 22 THE ERGE RED MORE ↗ Powering N3C / UNITE, an effort from NIH to collaborate with clinical and research instuons. NIH’s N3C is the largest COVID-19 clinical data asset in the world, with over 1 million paents across more than 30 hospitals — all assembled in Foundry in less than 5 months. WTCH VIDEO ↗ -- 17 of 40 -- RED MORE ↗ Supporng the complex supply chain and logiscs for COVID-19 vaccine distribuon. Palanr to Help U.S. Track Covid-19 Vaccines OCT 22, 22 LL STREET JOURNL–BUSNESS RED MORE ↗ -- 18 of 40 -- We are powering secure cross-border collaboraon for pandemic response and beyond. -- 19 of 40 -- RED MORE ↗ Powering the NHS England’s allocaon and distribuon of more than 2.7 billion pieces of PPE, from port to paent. All data is noonal. -- 20 of 40 -- All data is noonal. Supporng the President of Colombia through the naon’s pandemic response. RED MORE ↗ -- 21 of 40 -- FNNCL UPDTE © 22 Palanr Technologies Inc. -- 22 of 40 -- Revenue FG 3 REENUE Q3 219 Q3 22 $191M $289M +52% We grew our revenue by 52% year-over-year in Q3 2020. GROTH -- 23 of 40 -- We connue to grow exisng contracts as our customers derive more value from their software subscripons. Average Revenue Per Customer FG 4 ERGE REENUE Average Revenue of Top 20 Customers FG 5 ERGE REENUE GROTH GROTH 9 MONTHS ENDED SEPTEMBER 3, 219 9 MONTHS ENDED SEPTEMBER 3, 22 $4.2M $5.8M +38% 9 MONTHS ENDED SEPTEMBER 3, 219 9 MONTHS ENDED SEPTEMBER 3, 22 $17.4M $23.6M We define a customer as an organizaon from which we have recognized revenue in a reporng period. For large government agencies, where a single instuon has mulple divisions, units, or subsidiary agencies, each such division, unit, or subsidiary agency that enters into a separate contract with us and is invoiced as a separate enty is treated as a separate customer. +36% -- 24 of 40 -- Q3 219 Q3 22 ($92M) $73M (48%) 25% Adjusted Operang Income (Loss) FG 6 DJUSTED OPERTNG NCOME (LOSS) Our adjusted operang income in Q3 2020 was $73 million, and adjusted operang margin was 25%. DJUSTED OPERTNG MRGN Adjusted operang income (loss) excludes stock-based compensaon, expenses primarily related to our direct lisng, and employer payroll taxes related to stock-based compensaon. Refer to the Appendix for reconciliaons of these non-GAAP financial measures to the most directly comparable GAAP measures. -- 25 of 40 -- 9 MONTHS ENDED SEPTEMBER 3, 219 9 MONTHS ENDED SEPTEMBER 3, 22 Revenue from our top 20 customers connues to grow, while customer concentraon is decreasing. FG 7 FG 8 In the 9 months ended September 30, 2019, revenue from our top 20 customers comprised 68% of total revenue. In the 9 months ended September 30, 2020, revenue from our top 20 customers comprised 61% of total revenue. $348M $471M REENUE FROM TOP 20 CUSTOMERS REENUE FROM TOP 20 CUSTOMERS -- 26 of 40 -- $94M $127M $94M +35% $300 million license renewal in the aerospace industry starng in 2021 New deals across a variety of vercals, including consumer goods, healthcare, and financial services In Q3 2020, our commercial business grew 35% year-over-year, and we signed the largest commercial deal in our history. Commercial Revenue FG 9 GROTH REENUE Q3 219 Q3 22 -- 27 of 40 -- $163M $97M +68% In Q3 2020, our government business grew 68% year-over-year. Government Revenue FG 1 GROTH REENUE Q3 219 Q3 22 Two-year, $91 million contract with the U.S. Army Research Laboratory $36 million, IDIQ award with the Naonal Center for Advancing Translaonal Sciences RED MORE ↗ RED MORE ↗ -- 28 of 40 -- Acquire Phase FG 11 Expand Phase FG 12 Scale Phase FG 13 REENUE CONTRBUTON REENUE CONTRBUTON MRGN REENUE CONTRBUTON MRGN We accelerated growth in all three phases of our business model. $19M $41M ($14M) ($4M) $161M $254M 35% 41% $296M $452M 68% 69% 6 MONTHS ENDED JUNE 3, 22 9 MONTHS ENDED SEPTEMBER 3, 22 6 MONTHS ENDED JUNE 3, 22 9 MONTHS ENDED SEPTEMBER 3, 22 6 MONTHS ENDED JUNE 3, 22 9 MONTHS ENDED SEPTEMBER 3, 22 -- 29 of 40 -- $22.8M $8.3M +175% In addion to customers accounted for by our three-phase model, revenue from customers acquired in the 9 months ended September 30, 2020 grew by 175% year-over-year. GROTH REENUE FG 14 Revenue from Customers Acquired in the 9 Months Ended September 30, 2019 and 2020 We are signing up new customers and converng them to significant revenue-generang posions in record me. 9 MONTHS ENDED SEPTEMBER 3, 219 9 MONTHS ENDED SEPTEMBER 3, 22 The customers acquired in the nine months ended September 30, 2019 were not in a cohort as of December 31, 2018, and were assigned a cohort as of December 31, 2019. The customers acquired in the nine months ended September 30, 2020 were not in a cohort as of December 31, 2019, and will be assigned a cohort as of December 31, 2020. -- 30 of 40 -- Gross margin, excluding stock-based compensaon, is a non-GAAP financial measure. Refer to the Appendix for reconciliaons of this non-GAAP financial measure to the most directly comparable GAAP measure. 81% 7% Our gross margin, excluding stock-based compensaon, was 81%, up from 70% in Q3 2019. Gross Margin, Excluding Stock-Based Compensaon FG 15 Q3 219 Q3 22 GROSS MRGN, EXCLUDNG STOCK-BSED COMPENSTON -- 31 of 40 -- We have strong and increased visibility into future revenue across our customer base. We calculate expected average contract duraon on a dollar-weighted basis. Expected average duraon includes exisng contractual obligaons and assumes that our customers exercise all of the contractual opons available to them and do not terminate for convenience. Expected Average Contract Duraon FG 16 EXPECTED ERGE DURTON (ERS) 3.5 3.6 Q2 22 Q3 22 -- 32 of 40 -- We connue to have a strong balance sheet. $1.8B Cash and cash equivalents as of September 30, 2020 -- 33 of 40 -- GUDNCE © 22 Palanr Technologies Inc. -- 34 of 40 -- With strong visibility into future revenue and the connued acceleraon of our business, we are raising our full-year 2020 revenue and adjusted operang income guidance. 2020 Revenue Guidance FG 17 2020 Adjusted Operang Income Guidance FG 18 GUDNCE GROTH 22 $1.71B +44% 22 $133M 12% GUDNCE DJUSTED OPERTNG MRGN Adjusted operang income excludes stock-based compensaon and employer payroll taxes related to stock-based compensaon as well as direct lisng related costs. A reconciliaon of adjusted operang income to the corresponding GAAP measure is not available on a forward-looking basis without unreasonable effort due to the uncertainty regarding, and the potenal variability of, reconciling items that may be incurred in the future such as stock-based compensaon, and employer payroll taxes related to stock-based compensaon, the effect of which may be significant. For 2020 guidance, numbers reflect the midpoint of the esmated range for such measures. -- 35 of 40 -- GUDNCE GROTH GUDNCE DJUSTED OPERTNG MRGN We are expecng 31% revenue growth in Q4 2020, and year-over-year revenue growth to be greater than 30% through 2021. Q4 2020 Revenue Guidance FG 19 Q4 2020 Adjusted Operang Income Guidance FG 2 Adjusted operang income excludes stock-based compensaon and employer payroll taxes related to stock-based compensaon as well as direct lisng related costs. A reconciliaon of adjusted operang income to the corresponding GAAP measure is not available on a forward-looking basis without unreasonable effort due to the uncertainty regarding, and the potenal variability of, reconciling items that may be incurred in the future such as stock-based compensaon, and employer payroll taxes related to stock-based compensaon, the effect of which may be significant. For Q4 2020 guidance, numbers reflect the midpoint of the esmated range for such measures. Q4 22 $3M +31% Q4 22 $47M 16% -- 36 of 40 -- PPENDX © 22 Palanr Technologies Inc. -- 37 of 40 -- All figures in reconciliaon tables are unaudited. The tables present direct or indirect reconciliaons of the selected non-GAAP financial measures to the most comparable GAAP financial measures. ($k) Gross Profit Add: Stock-Based Compensaon Gross Profit, Excluding Stock-Based Compensaon $125,468 $7,183 Q3 2019 $132,651 7% $140,026 $94,385 Q3 2020 $234,411 81% Gross Margin, Excluding Stock-Based Compensaon Reconciliaon of Gross Profit to Gross Profit and Gross Margin, Excluding Stock-Based Compensaon -- 38 of 40 -- Reconciliaon of Loss from Operaons to Contribuon Margin All figures in reconciliaon tables are unaudited. The tables present direct or indirect reconciliaons of the selected non-GAAP financial measures to the most comparable GAAP financial measures. ($k) Loss from Operaons Add: Research and Development Expenses, Excluding Stock-Based Compensaon General and Administrave Expenses, Excluding Stock-Based Compensaon Stock-Based Compensaon Contribuon ($169,33) 6 MONTHS ENDED JUNE 3, 22 $231,636 48% ($1,17,17) $99,686 $156,832 $119,325 $226,455 $181,955 $1,28,914 9 MONTHS ENDED SEPTEMBER 3, 22 $395,94 51% Contribuon Margin -- 39 of 40 -- Reconciliaon of Loss from Operaons to Adjusted Operang Income (Loss) and Adjusted Operang Margin All figures in reconciliaon tables are unaudited. The tables present direct or indirect reconciliaons of the selected non-GAAP financial measures to the most comparable GAAP financial measures. Non-recurring charges includes charges related to the Direct Lisng and public company readiness iniaves. ($k) Loss from Operaons Add: Stock-Based Compensaon and Related Employer Payroll Taxes Non-Recurring Charges Adjusted Operating Income (Loss) Adjusted Operang Margin ($144,14) Q3 2019 ($92,377) ($847,777) $51,763 $867,131 – $53,737 Q3 2020 $73,91 (48%) 25% -- 40 of 40 --